ZY

Zymergen Inc.

  • CIK: 0001645842
  • EIN: 46-2942439
  • Business address: 5959 HORTON STREET, SUITE 700, EMERYVILLE, California, 94608

Information

  • Mailing address
    5959 HORTON STREET, SUITE 700, EMERYVILLE, Delaware, 94608
  • Phone
    (415) 801-8073
  • State location
    California
  • State of incorporation
    Delaware
  • Fiscal year end
    December 31
  • SIC
    8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
  • Filings
    N/A

About Zymergen Inc.

Zymergen Inc. (CIK: 0001645842) is an American company incorporated in the state of California. Head office is located at 5959 HORTON STREET, SUITE 700, EMERYVILLE, California, 94608. Work in the industry 8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH. Zymergen Inc. is a public company and trade via Over-The-Counter (OTC).

Ownership

Owner Filings Transaction Date Type of Owner
Kim Mina 0001668163 Oct-26-2021 officer: Chief Legal Officer
Singh Enakshi 0001846617 Oct-26-2021 officer: Chief Financial Officer
FLATLEY JAY T 0001189130 Apr-21-2021 director
PETERSON SANDRA E 0001192752 Apr-21-2021 director
Chu Steven 0001296381 Apr-21-2021 director
Gorjanc Christine Marie 0001345082 Apr-21-2021 director
SB INVESTMENT ADVISERS (UK) LTD 0001731509 Apr-21-2021 10 percent owner
SOFTBANK VISION FUND (AIV M1) L.P. 0001755143 Apr-21-2021 10 percent owner
SVF Endurance (Cayman) Ltd 0001782338 Apr-21-2021 10 percent owner
Ocko Matthew 0001836089 Apr-21-2021 director
SVF Excalibur (Cayman) Ltd 0001836869 Apr-21-2021 10 percent owner
Kimball Aaron 0001845645 Apr-21-2021 officer: Chief Technology Officer
Serber Zachariah 0001845655 Apr-21-2021 director, officer: Chief Science Officer
Murdoch Travis 0001845681 Apr-21-2021 director
Sharma Rohit 0001845689 Apr-21-2021 director
Dean Erik Jedidiah 0001845705 Apr-21-2021 officer: VP Operations and Engineering
Hoffman Josh 0001846885 Apr-21-2021 director, officer: Chief Executive Officer

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Zymergen Inc.

Filings Format Description Filed/Effective File/Film Number
15-12G Document

Notice of termination of registration of a class of securities under Section 12(g)

Acc-no: 0001193125-22-273993 (34 Act) Size: KB		 Oct-31-2022

001-40354

221346772
EFFECT Document Acc-no: 9999999995-22-003128 (33 Act) Size: KB Oct-25-2022

333-264907

221330954
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0001193125-22-266773 (34 Act) Size: KB		 Oct-21-2022

005-92516

221324090
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000899243-22-033957 ( Act) Size: 0 KB		 Oct-21-2022

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001645842-22-000149 ( Act) Size: 0 KB		 Oct-19-2022

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001645842-22-000147 ( Act) Size: 0 KB		 Oct-19-2022

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001645842-22-000144 ( Act) Size: 0 KB		 Oct-19-2022

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001645842-22-000142 ( Act) Size: 0 KB		 Oct-19-2022

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001645842-22-000140 ( Act) Size: 0 KB		 Oct-19-2022

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001645842-22-000138 ( Act) Size: 0 KB		 Oct-19-2022

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001645842-22-000136 ( Act) Size: 0 KB		 Oct-19-2022

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001645842-22-000131 ( Act) Size: 0 KB		 Oct-19-2022

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001645842-22-000130 ( Act) Size: 0 KB		 Oct-19-2022

POS AM Document

Post-effective amendment to a registration statement that is not immediately effective upon filing

Acc-no: 0001193125-22-265059 (33 Act) Size: KB		 Oct-19-2022

333-264907

221317911
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001193125-22-265042 (33 Act) Size: KB		 Oct-19-2022

333-263979

221317892
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001193125-22-265040 (33 Act) Size: KB		 Oct-19-2022

333-255450

221317889
8-K Document

Current report filing

Acc-no: 0001193125-22-264951 (34 Act) Size: KB		 Oct-19-2022

001-40354

221317695
25-NSE Document Acc-no: 0001354457-22-000577 (34 Act) Size: KB Oct-19-2022

001-40354

221317262
8-K Document

Current report filing

Acc-no: 0001193125-22-263929 (34 Act) Size: KB		 Oct-18-2022

001-40354

221314738
425 Document

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Acc-no: 0001193125-22-263927 (34 Act) Size: 0 KB		 Oct-18-2022

001-40354

221314735

Recent 20 filings. View all Zymergen Inc. filings

Reviews

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Frequently Asked Questions

Tags:

  • Zymergen Inc. overview
  • Zymergen Inc. job
  • Zymergen Inc. stock
  • Zymergen Inc. ownership
  • Zymergen Inc. CEO
  • Zymergen Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

XXSYS TECHNOLOGIES INC /CA
Update: Aug 25, 2022
WHISTLER INC
Update: Aug 25, 2022
WCG Clinical, Inc.
Update: Aug 25, 2022
Viventia Biotech Inc.
Update: Aug 24, 2022
VIACELL INC
Update: Aug 24, 2022
VIACELL INC
Update: Aug 24, 2022

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 3763 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 1009 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 1344 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 2561 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 2403 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 1142 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 1379 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 4763 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 2535 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by